Selective, orally active cyclooxygenase-2 (COX-2) inhibitor. Produces potent analgesic, anti-inflammatory and antipyretic activities in vivo
. Reported to produce fewer gastrointestinal side effects than standard NSAIDs.��.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
Selective cyclooxygenase-2 inhibition by nimesulide in man.
Cullen et al.
The citations listed below are publications that use Tocris products. Selected citations for Nimesulide include:
Showing Results 1 - 3 of 3